Belupo

What Belupo does

Belupo d.d. is a Croatian pharmaceutical company headquartered in Koprivnica that manufactures and distributes a comprehensive portfolio spanning prescription drugs, OTC medications, herbal medicines, dietary supplements, cosmetics, medical devices, and auxiliary medicinal preparations. Its products cover therapeutic categories including pain and fever relief (Neofen, Lupocet, Knavon Akut), cardiovascular health (Aska Pro), allergies (Belodin A, Rinil), cold and flu (Lupocet Trio, Lupocet Flu Forte, Hederan, Naxil, Naxil Forte), liver and digestive health (Silymarin, Lordiar, Portalak Efekt), dermatological care (Belupo Skin Solutions, Alomax, Rojazol Derm, Herplex, Amofin), and oral health (Belosept, Zynol). The underlying technology is conventional generic pharmaceutical manufacturing and formulation, with no disclosed AI/ML, digital platform, or proprietary software stack in the source data.

Belupo operates as the pharmaceutical division of Podravka d.d., which wholly owns the company. It runs wholly-owned regional subsidiaries in Slovenia (Belupo d.o.o.), Slovakia (Belupo s.r.o.), North Macedonia (Belupo d.o.o.e.l.), and Bosnia and Herzegovina (Farmavita d.o.o.) for local production and distribution, and exports to more than 30 markets across Southeastern, Central, Eastern, Western, Southern, and Northern Europe plus Central Asia, Oceania, and Southeast Asia.

Revenue is generated through regulated unit sales of prescription and OTC products via traditional pharmaceutical distribution channels (pharmacies, hospitals, healthcare institutions, and wholesalers) and direct-to-consumer channels for OTC, herbal, supplement, and cosmetic lines. Pricing operates under per-market regulated pharmaceutical frameworks. Marketing and consumer engagement run through the corporate website (belupo.hr), dedicated brand websites for major SKUs (Neofen, Lupocet, Rinil, Silymarin, Aska Pro, Amofin, Belupo Skin Solutions), LinkedIn, Facebook, and Instagram under the 'Zdravo budi' health-and-wellness brand, plus a 'Belupoint' digital property.

Name

Belupo

Legal name

Belupo d.d.

Website

https://belupo.hr

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Belupo d.d. is a Croatian generic pharmaceutical manufacturer headquartered in Koprivnica and wholly owned by Podravka d.d., producing prescription drugs, OTC medications, herbal medicines, dietary supplements, cosmetics, and medical devices for healthcare providers, pharmacies, and consumers across more than 30 markets via subsidiaries in Slovenia, Slovakia, North Macedonia, and Bosnia and Herzegovina.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

akta.pro secondary industry

Digestive Health OTC (Antacids, Laxatives, Anti-diarrheals, Probiotics OTC) (CRADAMAE)

Keywords

• Generic pharmaceuticals
• OTC medications
• Dermatological products
• Herbal medicines
• Dietary supplements

Headquarters

HQ city

Zagreb

HQ country

Croatia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Pharmaceutical Products: Belupo generates revenue through the manufacturing and distribution of prescription drugs, OTC medications, herbal medicines, dietary supplements, cosmetics, medical devices, and auxiliary medicinal preparations. The company operates across multiple markets including Croatia, Slovenia, Slovakia, North Macedonia, and exports to over 25 countries worldwide.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Belupo is a pharmaceutical manufacturer and distributor producing prescription drugs, OTC medications, herbal medicines, dietary supplements, cosmetics, medical devices, and auxiliary medicinal preparations. The company sells its products across multiple therapeutic categories including pain and fever relief, cardiovascular health, allergies, cold and flu, digestive health, dermatology, and oral health, primarily in Croatia and across 30+ export markets.

Product overview

Belupo lijekovi i kozmetika, d.d. is a pharmaceutical company based in Koprivnica, Croatia, producing and distributing a comprehensive portfolio of pharmaceutical products. The company's product offering encompasses prescription drugs, over-the-counter (OTC) medications, herbal medicines, dietary supplements, cosmetics, medical products, and auxiliary medicinal preparations. The portfolio is organized across multiple therapeutic categories including pain and fever relief (Neofen, Lupocet, Knavon Akut, Luboreta), cardiovascular health (Aska Pro), allergies (Belodin A, Rinil), cold and flu (Lupocet Trio, Lupocet Flu Forte, Hederan, Naxil, Naxil Forte, Zynol), liver and digestive health (Silymarin, Lordiar, Portalak Efekt), dermatological care (Belupo Skin Solutions, Alomax, Rojazol Derm, Herplex, Amofin), and oral health (Belosept, Zynol sprays, Belodex). The company operates as a subsidiary of Podravka d.d. and has subsidiaries in Slovenia, Slovakia, North Macedonia, and Bosnia and Herzegovina, distributing products across more than 30 markets globally.

Differentiator

Problem solved

Functional benefit

Products and services

• Neofen Over-the-counter pain relief medication for pain and fever, marketed to consumers.
• Lupocet Pain and fever relief medication brand with multiple formulations including Lupocet Trio and Lupocet Flu Forte for cold and flu symptoms.
• Knavon Akut 50 mg hard capsules for pain relief.
• Luboreta 10 mg/g cream for topical pain relief.
• Aska Pro Cardiovascular medication for heart and blood vessel health.
• Belodin A 10 mg tablets for allergy treatment.
• Belodin A Derm Gel 1 mg/1 g gel formulation for skin allergy relief.
• Rinil Nasal medication for allergy and cold symptoms.
• Hederan Syrup for cold and cough relief.
• Naxil 200 mg effervescent tablets for cold and flu symptoms.
• Naxil Forte 600 mg effervescent tablets for stronger cold and flu relief.
• Zynol Oral mucosa spray medication available in 1.5 mg/ml and 3 mg/ml formulations for oral health.
• Silymarin Herbal liver support supplement.
• Lordiar 2 mg capsules for liver and digestive system support.
• Portalak Efekt 667 mg/ml syrup for digestive system relief.
• Belupo Skin Solutions Dermatological skincare product line for skin conditions and cosmetic care.
• Alomax 5% topical solution for skin and hair conditions.
• Rojazol Derm 20 mg/g cream for skin conditions including fungal infections.
• Herplex 50 mg/g cream for herpes treatment.
• Amofin Skincare product for skin conditions.
• Belodex Oral health product.
• Belosept Oral mucosa solution for oral health.

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered subsidiary and parent company.

• Belupo d.o.o. (Slovenia)subsidiaryOthersBelupo's subsidiary in Slovenia, fully owned by Belupo d.d., handles local production and distribution of pharmaceutical products in the Slovenian market.
• Belupo s.r.o. (Slovakia)subsidiaryOthersBelupo's subsidiary in Slovakia, fully owned by Belupo d.d., manages local operations and distribution of Belupo pharmaceutical products in Slovakia.
• Belupo d.o.e.l. (North Macedonia)subsidiaryOthersBelupo's subsidiary in North Macedonia, fully owned by Belupo d.d., handles operations in the Macedonian pharmaceutical market.
• Farmavita d.o.o. (BiH)subsidiaryOthersBelupo's subsidiary in Bosnia and Herzegovina, fully owned by Belupo d.d., manages pharmaceutical distribution and operations in the BiH market.
• Podravka d.d.parent companyOthersBelupo d.d. is wholly owned by Podravka d.d., a leading Croatian food and pharmaceutical company. Belupo operates as a subsidiary within the Podravka Group, benefiting from group synergies and shared infrastructure.

Scale indicators3 records

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• Sandoz: Standalone European generics and biosimilars company (formerly Novartis division) with leading global position in off-patent medicines. Directly competes with Belupo in European generic pharmaceutical markets with a significantly larger portfolio.
• Stada Arzneimittel: European generic and consumer healthcare company with broad generics, OTC, and specialty pharmaceutical portfolio across 30+ markets. Comparable to Belupo in geographic scope and OTC/generics mix, but materially larger and more diversified.
• Teva Pharmaceutical Industries: Global leader in generic pharmaceuticals with extensive product portfolio across all major therapeutic areas. Belupo competes with Teva in several export markets where Teva's scale and portfolio breadth outpace regional generic manufacturers.

Direct peers

• Polpharma: Poland's largest generic pharmaceutical manufacturer with diversified portfolio of prescription drugs, OTC, and dietary supplements across CEE markets. Comparable to Belupo in scale, geographic focus, and product mix across multiple therapeutic categories.
• Gedeon Richter: Hungarian pharmaceutical company with a broad portfolio of generic and branded drugs across cardiovascular, women's health, and CNS therapeutic areas. Comparable to Belupo in its CEE-anchored manufacturing base and balance of prescription and OTC products.
• Alkaloid: North Macedonian pharmaceutical manufacturer producing generic drugs, OTC products, cosmetics, and herbal medicines. A direct regional peer given proximity to Belupo's North Macedonian subsidiary and similar product portfolio across Rx and OTC.
• KRKA: Slovenian-headquartered generic pharmaceutical manufacturer with a comparable portfolio of prescription drugs, OTC products, herbal medicines, and animal health products sold across Central and Eastern Europe. KRKA is the most direct regional peer to Belupo in terms of geography, therapeutic mix, and generic focus.
• Zentiva: European-focused generic pharmaceutical manufacturer headquartered in Prague with broad portfolio across cardiovascular, pain, and respiratory categories. Directly comparable to Belupo in its generic-driven business model and CEE distribution footprint.

Regional players

• Lek (Sandoz): Slovenian pharmaceutical manufacturer now operating as a Sandoz subsidiary, producing generic drugs and OTC products in the Slovenian and CEE markets. Directly comparable to Belupo's Slovenian subsidiary (Belupo d.o.o.) in regional generic manufacturing.
• Bosnalijek: Bosnia and Herzegovina-based pharmaceutical manufacturer producing generic drugs, OTC products, and herbal medicines. A direct regional peer given geographic proximity to Belupo's BiH subsidiary (Farmavita) and overlapping product portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/belupocz
• LinkedInlinkedin.com/company/belupohr
• Instagraminstagram.com/zdravo_budi.hr?igsh=MXJrZ2Jsa3ZjaGN2aw==

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Belupo